NYSE:INSP
Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc.'s revenue grew 13.6% in fiscal 2025 to $912.0M while operating margin rose to 5.6%, its highest in 10 years. Free cash flow was $78.5M, 8.6% of revenue, and the diluted share count fell 2.6%.Summary generated from Inspire Medical Systems, Inc.'s SEC filings. Latest annual report filed Feb 13, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$912.0M
Revenue growth+13.6%
Revenue, 5-yr CAGR+51.2%
Gross margin85.4%
Operating margin5.6%
Net margin15.9%
ROICn/a
Return on equity19.8%
Debt / equityn/a
Free cash flow$78.5M
FCF margin8.6%
Share count change−2.6%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 233 | 408 | 625 | 803 | 912 |
| Operating income | −40 | −48 | −40 | 36 | 51 |
| Net income | −42 | −45 | −21 | 54 | 145 |
| Free cash flow | −25 | 2 | 1 | 91 | 78 |
Recent filings
- 4Insider transaction report
Sep 2, 2026 - 4Insider transaction report
Aug 11, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 3, 2026 - 8-KResults of operations and financial condition
Aug 3, 2026 - 8-KDirector or officer change
Jul 24, 2026 - 8-KDirector or officer change
Jul 22, 2026 - 8-KRegulation FD disclosure
Jun 26, 2026 - 8-KDirector or officer change
May 5, 2026